PRECISE

Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network
The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) is a five-year study sponsored by the National Heart, Lung, and Blood Institute (NHLBI). The study aims to identify more effective treatments for severe asthma, a disease that affects nearly 10% of people worldwide and remains poorly controlled for many patients. The study is an innovative clinical trial that will support a personalized medicine approach to identifying therapies that are tailored to an individual’s disease and treatment history.
Clinical Centers: 10
Participants: 800
Beginning:
Ending:
Funding: NHLBI
Study Design:
Clinical Trial